Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis

INTRODUCTION: Eosinophilic granulomatosis with polyangiitis (EGPA) is a subset of antineutrophil cytoplasmic antibodies (ANCA) associated vasculitis with distinct pathophysiological mechanisms, clinical features and treatment responses. Rituximab is a licensed therapy for granulomatosis with polyang...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:RMD Open
Main Authors: Teixeira, Vítor, Mohammad, Aladdin J, Jones, Rachel B, Smith, Rona, Jayne, David
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2019
Assuntos:
Vasculitis
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6560673/
https://ncbi.nlm.nih.gov/pubmed/31245051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2019-000905
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares